Randomized controlled trial of the effect of low dose aspirin on the course of agerelated macular degeneration

McNeil, John (Primary Chief Investigator (PCI))
Robman, Luba (Chief Investigator (CI))
Woods, Robyn (Chief Investigator (CI))
Guymer, Robyn Heather (Chief Investigator (CI))
Wolfe, Rory (Chief Investigator (CI))

Project: Research

1 Article

1 results

2020

Baseline characteristics and age-related macular degeneration in participants of the “ASPirin in Reducing Events in the Elderly” (ASPREE)-AMD trial
Robman, L. D., Le, T. P. T., Guymer, R. H., Wolfe, R., Woods, R. L., Hodgson, L. A. B., Phung, J., Makeyeva, G. A., Le-Pham, Y-A., Orchard, S., Suleiman, J., Maguire, E., Trevaks, R. E., Ward, S. A., Riaz, M., Lacaze, P., Storey, E., Abhayaratna, W. P., Nelson, M. R., Ernst, M. E., & 3 othersReid, C. M., McNeil, J. & the ASPREE Investigator Group, Dec 2020, In: Contemporary Clinical Trials Communications. 20, 34 p., 100667.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

5 Citations (Scopus)